Targeting G protein-coupled receptors for the treatment of chronic pain in the digestive system.


Journal

Gut
ISSN: 1468-3288
Titre abrégé: Gut
Pays: England
ID NLM: 2985108R

Informations de publication

Date de publication:
05 2021
Historique:
received: 23 03 2020
revised: 21 10 2020
accepted: 07 11 2020
pubmed: 5 12 2020
medline: 15 12 2021
entrez: 4 12 2020
Statut: ppublish

Résumé

Chronic pain is a hallmark of functional disorders, inflammatory diseases and cancer of the digestive system. The mechanisms that initiate and sustain chronic pain are incompletely understood, and available therapies are inadequate. This review highlights recent advances in the structure and function of pronociceptive and antinociceptive G protein-coupled receptors (GPCRs) that provide insights into the mechanisms and treatment of chronic pain. This knowledge, derived from studies of somatic pain, can guide research into visceral pain. Mediators from injured tissues transiently activate GPCRs at the plasma membrane of neurons, leading to sensitisation of ion channels and acute hyperexcitability and nociception. Sustained agonist release evokes GPCR redistribution to endosomes, where persistent signalling regulates activity of channels and genes that control chronic hyperexcitability and nociception. Endosomally targeted GPCR antagonists provide superior pain relief in preclinical models. Biased agonists stabilise GPCR conformations that favour signalling of beneficial actions at the expense of detrimental side effects. Biased agonists of µ-opioid receptors (MOPrs) can provide analgesia without addiction, respiratory depression and constipation. Opioids that preferentially bind to MOPrs in the acidic microenvironment of diseased tissues produce analgesia without side effects. Allosteric modulators of GPCRs fine-tune actions of endogenous ligands, offering the prospect of refined pain control. GPCR dimers might function as distinct therapeutic targets for nociception. The discovery that GPCRs that control itch also mediate irritant sensation in the colon has revealed new targets. A deeper understanding of GPCR structure and function in different microenvironments offers the potential of developing superior treatments for GI pain.

Identifiants

pubmed: 33272979
pii: gutjnl-2020-321193
doi: 10.1136/gutjnl-2020-321193
pmc: PMC9716638
mid: NIHMS1852083
doi:

Substances chimiques

Analgesics 0
Ligands 0
Receptors, G-Protein-Coupled 0
Sensory System Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

970-981

Subventions

Organisme : NIDCR NIH HHS
ID : R01 DE026806
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE029951
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK118971
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS102722
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: NWB is a founding scientist of Endosome Therapeutics Inc.

Références

Am J Physiol Gastrointest Liver Physiol. 2018 Oct 1;315(4):G544-G559
pubmed: 29927325
Nat Commun. 2019 Jan 21;10(1):367
pubmed: 30664663
Gastroenterology. 2019 May;156(6):1600-1616
pubmed: 30771352
Semin Cancer Biol. 2017 Apr;43:119-133
pubmed: 28188829
Sci Rep. 2017 Oct 19;7(1):13606
pubmed: 29051514
Am J Physiol Gastrointest Liver Physiol. 2015 Aug 15;309(4):G248-59
pubmed: 26138465
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17615-22
pubmed: 19822761
Cell Tissue Res. 2014 May;356(2):319-32
pubmed: 24728885
Science. 2020 Feb 21;367(6480):888-892
pubmed: 32079768
J Neurosci. 2000 Nov 15;20(22):RC110
pubmed: 11069979
Br J Pharmacol. 2018 Jul;175(13):2622-2634
pubmed: 29579315
Br J Anaesth. 2019 Jun;122(6):e136-e145
pubmed: 31010646
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4760-5
pubmed: 9539812
Neurogastroenterol Motil. 2019 Aug;31(8):e13623
pubmed: 31119828
Expert Opin Pharmacother. 2019 Dec;20(17):2073-2080
pubmed: 31557072
Science. 1999 Dec 24;286(5449):2495-8
pubmed: 10617462
Annu Rev Physiol. 2019 Feb 10;81:261-284
pubmed: 30379615
Int J Colorectal Dis. 2019 Feb;34(2):217-227
pubmed: 30564910
Oncotarget. 2017 Jan 3;8(1):705-721
pubmed: 27893428
Expert Opin Investig Drugs. 2017 Feb;26(2):155-160
pubmed: 28001096
Nat Rev Gastroenterol Hepatol. 2014 Oct;11(10):611-27
pubmed: 25001973
Gastroenterology. 2014 Dec;147(6):1417-28
pubmed: 25194674
Cell. 2009 Jun 12;137(6):1148-59
pubmed: 19524516
Dig Dis Sci. 2019 Mar;64(3):729-739
pubmed: 30446929
J Cell Biol. 2000 Mar 20;148(6):1267-81
pubmed: 10725339
Alzheimers Dement (N Y). 2018 Apr 26;4:173-181
pubmed: 29955661
Pain. 2019 Jan;160(1):19-27
pubmed: 30586067
Neurosignals. 2005;14(4):158-65
pubmed: 16215298
Gastroenterology. 2013 Aug;145(2):329-38.e1
pubmed: 23583433
Science. 2017 Mar 3;355(6328):966-969
pubmed: 28254944
Cell Death Dis. 2016 Jul 14;7:e2294
pubmed: 27415424
Pain Pract. 2019 Sep;19(7):715-731
pubmed: 31162798
J Psychopharmacol. 2017 Jun;31(6):730-739
pubmed: 28142305
Sci Signal. 2018 Dec 18;11(561):
pubmed: 30563864
Neuron. 2015 Nov 18;88(4):635-49
pubmed: 26590341
Am J Physiol Gastrointest Liver Physiol. 2016 Feb 1;310(3):G215-23
pubmed: 26564719
Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):947-51
pubmed: 7508124
J Pharmacol Exp Ther. 2005 Sep;314(3):1195-201
pubmed: 15917400
Nat Nanotechnol. 2019 Dec;14(12):1150-1159
pubmed: 31686009
J Med Chem. 2015 May 28;58(10):4220-9
pubmed: 25901762
Cell. 2009 Dec 24;139(7):1353-65
pubmed: 20004959
Trends Pharmacol Sci. 2018 Oct;39(10):879-891
pubmed: 30180973
J Neurosci. 2004 May 5;24(18):4300-12
pubmed: 15128844
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10830-5
pubmed: 23754417
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15281-15292
pubmed: 32546520
Mol Pharmacol. 2018 Apr;93(4):266-269
pubmed: 29348268
Gastroenterology. 2011 Nov;141(5):1864-74.e1-3
pubmed: 21802389
Neurogastroenterol Motil. 2013 Jan;25(1):39-46.e4
pubmed: 22963585
J Clin Invest. 2007 Mar;117(3):636-47
pubmed: 17304351
Methods Cell Biol. 2019;149:155-178
pubmed: 30616817
Gastroenterology. 2013 Jan;144(1):145-54
pubmed: 23041323
Dig Dis Sci. 2016 Oct;61(10):2878-2886
pubmed: 27250983
Gut. 2017 Oct;66(10):1767-1778
pubmed: 28096305
Am J Physiol Gastrointest Liver Physiol. 2017 Jun 1;312(6):G635-G648
pubmed: 28385695
Neuron. 2018 Jun 6;98(5):963-976.e5
pubmed: 29754753
Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):E7438-E7447
pubmed: 30012612
Drug Des Devel Ther. 2019 Oct 30;13:3753-3772
pubmed: 31802849
Mucosal Immunol. 2015 Jan;8(1):68-79
pubmed: 24866378
Gut. 2010 Apr;59(4):481-8
pubmed: 20332520
Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G34-42
pubmed: 19423751
J Biol Chem. 2014 Sep 26;289(39):27215-27234
pubmed: 25118282
J Clin Invest. 2003 May;111(9):1329-38
pubmed: 12727924
J Biol Chem. 2015 May 29;290(22):13875-87
pubmed: 25878251
Sci Transl Med. 2017 May 31;9(392):
pubmed: 28566424
Neuron. 1999 Sep;24(1):243-52
pubmed: 10677041
Science. 2020 Feb 21;367(6480):881-887
pubmed: 32079767
Gastroenterology. 2015 Dec;149(7):1884-1895.e4
pubmed: 26261008
Nat Rev Dis Primers. 2020 Jan 6;6(1):1
pubmed: 31907359
Front Pharmacol. 2019 Feb 19;10:125
pubmed: 30837883
Inflamm Bowel Dis. 2018 Feb 15;24(3):558-572
pubmed: 29462379
PLoS One. 2016 Mar 10;11(3):e0150861
pubmed: 26963721
NCHS Data Brief. 2018 Nov;(329):1-8
pubmed: 30500323
Curr Pain Headache Rep. 2017 Jan;21(1):2
pubmed: 28097532
Nat Rev Gastroenterol Hepatol. 2015 Nov;12(11):649-59
pubmed: 26460352
JCI Insight. 2019 Oct 17;4(20):
pubmed: 31536477
Neuroscience. 2011 Oct 13;193:440-51
pubmed: 21763756
Gut Liver. 2016 May 23;10(3):382-90
pubmed: 26446924
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
Gastroenterology. 2015 Aug;149(2):433-44.e7
pubmed: 25911511
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5135-9
pubmed: 15044695
Sci Rep. 2018 Jun 12;8(1):8965
pubmed: 29895890
Am J Physiol Gastrointest Liver Physiol. 2006 May;290(5):G959-69
pubmed: 16399878
Curr Opin Pharmacol. 2006 Dec;6(6):559-63
pubmed: 16935560
Nature. 2006 Dec 14;444(7121):894-8
pubmed: 17167479
Sci Signal. 2020 Mar 31;13(625):
pubmed: 32234959
Physiol Rev. 2014 Jan;94(1):265-301
pubmed: 24382888
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):12309-12314
pubmed: 29087309
Trends Pharmacol Sci. 2019 Dec;40(12):1006-1020
pubmed: 31711626
FEBS J. 2020 Feb;287(4):645-658
pubmed: 31495063
Br J Pharmacol. 2020 Jul;177(13):2923-2931
pubmed: 32052419
PLoS One. 2015 Feb 27;10(2):e0114831
pubmed: 25723478
Neuropharmacology. 2020 Apr;166:107678
pubmed: 31278929
Nat Rev Mol Cell Biol. 2018 Oct;19(10):638-653
pubmed: 30104700
Aliment Pharmacol Ther. 2004 Jul 15;20(2):237-46
pubmed: 15233705

Auteurs

Lena Gottesman-Katz (L)

Molecular Pathobiology, New York University, New York, New York, USA.
Division of Pediatric Gastroenterology, Columbia University Medical Center/New York Presbyterian, New York, New York, USA.

Rocco Latorre (R)

Molecular Pathobiology, New York University, New York, New York, USA.

Stephen Vanner (S)

Gastrointestinal Diseases Research Unit, Division of Gastroenterology, Queens University, Kingston, Ontario, Canada.

Brian L Schmidt (BL)

Bluestone Center, New York University, New York, New York, USA.

Nigel W Bunnett (NW)

Molecular Pathobiology, New York University, New York, New York, USA nwb2@nyu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH